Breakout Ventures raises $114M fund to back AI science startups
Summary
Breakout Ventures has successfully closed its Fund III, raising $114 million to invest in early-stage startups that apply artificial intelligence to scientific domains like biology and chemistry. This new fund aims to support at least 20 companies, with individual investments ranging from $500,000 to $5 million. The firm, which originated from a Thiel Foundation grant program and officially launched in 2016, previously raised a $60 million Fund I in 2017 and a $112.5 million Fund II in 2021, both also targeting science-focused ventures. Fund III's capital was secured over approximately 18 months from limited partners including The Kraft Group, Pinegrove Venture Partners, and Cubed Capital.
Key takeaway
For entrepreneurs developing AI-powered solutions in biology or chemistry, Breakout Ventures' Fund III represents a significant funding opportunity. You should emphasize how your technology addresses massive unmet needs and demonstrate a clear founder-market fit. Prepare to articulate your scientific innovation and its commercial potential to attract investments ranging from $500,000 to $5 million.
Key insights
Breakout Ventures' Fund III targets AI-driven scientific startups, emphasizing founder-market fit.
Principles
- AI can solve unmet needs in biology and chemistry.
- Founder-market fit is critical for early-stage science ventures.
In practice
- Seek funding from specialized science VCs.
- Highlight AI's role in scientific problem-solving.
Topics
- Venture Capital
- AI Startups
- Biotech Investment
- Chemistry Innovation
- Early-stage Funding
Best for: Investor, Entrepreneur, Business Analyst
Related on AIssential
Editorial summary, takeaway, and curation by AIssential. Original article published by TechCrunch.